Pharmafile Logo

BRACE trial

https://youtu.be/5jUf-4v_g7w

Attacking COVID-19 from All Angles

Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...

Impetus Digital

- PMLiVE

Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM

Editorial highlights issues with WHO’s Solidarity trial

- PMLiVE

US secures 650,000 additional doses of Lilly’s COVID-19 antibody

This takes the total purchased amount to 950,000 doses

- PMLiVE

WHO set to review Pfizer/BioNTech COVID-19 vaccine for emergency use listing

Follows approval for emergency use in the UK yesterday

- PMLiVE

EMA launches rolling review of J&J’s COVID-19 vaccine

Vaccine entered phase 3 testing in September

- PMLiVE

Novavax moves closer toward launch of US phase 3 COVID-19 vaccine trial

Company also completes enrolment in UK-based phase 3 trial

- PMLiVE

Pfizer/BioNTech’s COVID-19 vaccine gets first approval from UK

The UK has already signed a supply deal for 40 million doses

- PMLiVE

Joint COVID-19 trial begins testing drugs from Amgen, UCB and Takeda

Trial will test therapeutic candidates in hospitalised COVID-19 patients

- PMLiVE

Moderna eyes COVID-19 vaccine approval in the US and the EU

Updated analysis demonstrates efficacy of 94.1%

- PMLiVE

AZ, Oxford University face more scrutiny over COVID-19 vaccine data

WHO’s immunisations director says ‘more than a press release’ is needed

- PMLiVE

COVID-19 infections in England drop by 30% amid national lockdown

Observations come from REACT study led by Imperial College London and Ipsos MORI

- PMLiVE

Moderna and UK sign agreement for additional doses of COVID-19 vaccine

The UK has secured another two million doses on top of previously agreed five million doses

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links